Litman Gregory Wealth Management LLC Sells 220 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Litman Gregory Wealth Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 22,946 shares of the healthcare conglomerate’s stock after selling 220 shares during the quarter. UnitedHealth Group makes up 1.1% of Litman Gregory Wealth Management LLC’s investment portfolio, making the stock its 21st largest position. Litman Gregory Wealth Management LLC’s holdings in UnitedHealth Group were worth $12,080,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Robbins Farley purchased a new stake in UnitedHealth Group during the 3rd quarter worth about $25,000. Richelieu Gestion SA purchased a new stake in UnitedHealth Group during the 4th quarter worth about $26,000. CGC Financial Services LLC lifted its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC lifted its holdings in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 1.6 %

Shares of UNH stock traded up $8.11 during trading hours on Friday, reaching $501.29. The company’s stock had a trading volume of 6,616,632 shares, compared to its average volume of 4,553,088. The stock has a market capitalization of $462.16 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.31 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The firm’s fifty day simple moving average is $488.63 and its 200 day simple moving average is $515.13. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the company earned $6.26 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 45.97%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday. Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Finally, Barclays raised their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.